Emily’s Entourage Appoints David A. Waltz, MD, as First Chief Medical Officer
Veteran cystic fibrosis physician-scientist and former Vertex Pharmaceuticals senior leader to help accelerate therapies for the final 10% of people with cystic fibrosis Philadelphia, PA—March 17, 2026—Emily’s Entourage (EE), an innovative 501(c)(3) organization accelerating new treatments and a cure for the final 10% of people with cystic fibrosis (CF) that do not benefit from existing CFTR modulator therapies, today announced the appointment... Per saperne di più
